Oncology & Cancer

ASCO: VTE is risk factor for recurrence in esophageal cancer

(HealthDay)—For patients with esophageal cancer, venous thromboembolism (VTE) is a risk factor for recurrence, according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers ...

Diseases, Conditions, Syndromes

CYP2C19 polymorphism impacts response to PPI Tx in GERD

(HealthDay)—CYP2C19 polymorphism impacts response to proton pump inhibitor (PPI) treatment in gastroesophageal reflux disease (GERD), with lower efficacy rates for rapid metabolizer (RM) genotypes, according to a study ...

Oncology & Cancer

Study: Microendoscope could eliminate unneeded biopsies

In a clinical study of patients in the United States and China, researchers found that a low-cost, portable, battery-powered microendoscope developed by Rice University bioengineers could eventually eliminate the need for ...

Medical research

First step: From human cells to tissue-engineered esophagus

In a first step toward future human therapies, researchers at The Saban Research Institute of Children's Hospital Los Angeles have shown that esophageal tissue can be grown in vivo from both human and mouse cells. The study ...

Oncology & Cancer

Team discovers stem cells in the esophagus

Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. ...

page 14 from 26